|
Volumn 21, Issue 6, 2015, Pages 555-559
|
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
a b,c,t d e b,c d,f a a a b,c b,c b,c b,c b g g g g,u h,i j more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
DNA;
HISTONE DEMETHYLASE INHIBITOR;
HISTONE H3;
OXYGENASE INHIBITOR;
PANOBINOSTAT;
UNCLASSIFIED DRUG;
VORINOSTAT;
BENZAZEPINE DERIVATIVE;
GSK-J4;
HYDROXAMIC ACID;
INDOLE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CELL VIABILITY;
CONTROLLED STUDY;
DRUG EFFICACY;
EXOME;
GENE EXPRESSION;
GENE SILENCING;
HUMAN;
HUMAN TISSUE;
IN VITRO STUDY;
IN VIVO STUDY;
MOUSE;
NONHUMAN;
PONTINE GLIOMA;
PRIORITY JOURNAL;
RNA SEQUENCE;
SEQUENCE ANALYSIS;
ANIMAL;
BRAIN STEM NEOPLASMS;
DISEASE MODEL;
DRUG POTENTIATION;
DRUG SCREENING;
GENETICS;
GLIOMA;
PATHOLOGY;
ANIMALS;
BENZAZEPINES;
BRAIN STEM NEOPLASMS;
DISEASE MODELS, ANIMAL;
DRUG SYNERGISM;
GLIOMA;
HUMANS;
HYDROXAMIC ACIDS;
INDOLES;
PYRIMIDINES;
SEQUENCE ANALYSIS, RNA;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 84930764914
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm.3855 Document Type: Article |
Times cited : (454)
|
References (25)
|